A detailed history of Us Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Us Asset Management LLC holds 3,986 shares of ABBV stock, worth $705,322. This represents 0.74% of its overall portfolio holdings.

Number of Shares
3,986
Previous 4,075 2.18%
Holding current value
$705,322
Previous $698,000 12.75%
% of portfolio
0.74%
Previous 0.64%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $14,581 - $17,740
-89 Reduced 2.18%
3,986 $787,000
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $14,550 - $16,991
-94 Reduced 2.25%
4,075 $698,000
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $411,536 - $468,907
-2,575 Reduced 38.18%
4,169 $759,000
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $9,494 - $10,692
69 Added 1.03%
6,744 $1.05 Million
Q2 2023

Aug 22, 2023

SELL
$132.51 - $164.9 $47,571 - $59,199
-359 Reduced 5.1%
6,675 $899,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $7,519 - $8,660
-52 Reduced 0.73%
7,034 $1.12 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $2,904 - $3,483
-21 Reduced 0.3%
7,086 $1.15 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $5,091 - $6,473
37 Added 0.52%
7,107 $1.09 Million
Q1 2022

Apr 08, 2022

BUY
$131.98 - $163.75 $7,522 - $9,333
57 Added 0.81%
7,070 $1.15 Million
Q4 2021

Mar 30, 2022

SELL
$107.43 - $135.93 $6,553 - $8,291
-61 Reduced 0.86%
7,013 $950,000
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $752,673 - $854,397
7,074 New
7,074 $763,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Us Asset Management LLC Portfolio

Follow Us Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Us Asset Management LLC with notifications on news.